Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This latest feature of MassDevice.com’s coverage highlights our three biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
Siemens AG (NYSE:SI) may cut as many as 2,000 positions from its diagnostics and radiation treatment divisions, shifting its focus to lower-cost countries and reducing costs.
Sen. Dick Lugar (R-Ind.), the head Republican on the Senate’s Foreign Affairs Committee, warned Chinese officials that its proposed price controls for medical products would hurt American companies and Chinese patients.
C.R. Bard (NYSE:BCR) doles out $325 million for Lutonix and its drug-coated angioplasty balloon devices, the only such devices with IDE clearance in the U.S.acquired.